Michael Laposata

Association of Cystic Fibrosis with Abnormalities in Fatty Acid Metabolism

Steven D. Freedman, Paola G. Blanco, Munir M. Zaman et al. · New England Journal of Medicine · 2004 · 399 citations · Full text

Life Sciences, Biochemistry, Genetics +17

A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in <i>cftr</i> ^−/− mice

Steven D. Freedman, Mark H. Katz, Eliza M. Parker et al. · Proceedings of the National Academy of Sciences · 1999 · 285 citations · Full text

Life Sciences, Biochemistry, Pathobiology +17

College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.

Michael Laposata, D Green, Elizabeth M. Van Cott et al. · PubMed · 1998 · 253 citations

Medicine, Hematology, Pharmacology +17

Expression of rat intestinal fatty acid-binding protein in Escherichia coli. Purification and comparison of ligand binding characteristics with that of Escherichia coli-derived rat liver fatty acid-binding protein.

John B. Lowe, James C. Sacchettini, Michael Laposata et al. · Journal of Biological Chemistry · 1987 · 250 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +7

Regulation of the phosphoinositide hydrolysis pathway in thrombin-stimulated platelets by a pertussis toxin-sensitive guanine nucleotide-binding protein. Evaluation of its contribution to platelet activation and comparisons with the adenylate cyclase inhibitory protein, Gi.

Lawrence F. Brass, Michael Laposata, H S Banga et al. · Journal of Biological Chemistry · 1986 · 232 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17